A. Donald Bergstrom's most recent trade in Relay Therapeutics Inc was a trade of 27,472 Common Stock done at an average price of $3 . Disclosure was reported to the exchange on April 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 28 Apr 2025 | 27,472 | 583,490 | - | 3 | 82,416 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 3.17 per share. | 28 Apr 2025 | 4,090 | 610,962 | - | 3.2 | 12,965 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 2.84 per share. | 27 Mar 2025 | 986 | 615,052 | - | 2.8 | 2,800 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 176,400 | 693,268 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 4.55 per share. | 28 Jan 2025 | 46,407 | 646,861 | - | 4.6 | 211,152 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 4.42 per share. | 28 Jan 2025 | 30,823 | 616,038 | - | 4.4 | 136,238 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 4.63 per share. | 28 Jan 2025 | 3,220 | 516,868 | - | 4.6 | 14,909 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 4.38 per share. | 27 Dec 2024 | 657 | 520,088 | - | 4.4 | 2,878 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 6.06 per share. | 28 Oct 2024 | 2,688 | 520,745 | - | 6.1 | 16,289 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 7.51 per share. | 27 Sep 2024 | 648 | 523,433 | - | 7.5 | 4,866 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 8.85 per share. | 29 Jul 2024 | 2,698 | 524,081 | - | 8.8 | 23,877 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 27 Jun 2024 | 648 | 526,779 | - | 6.3 | 4,056 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 6.38 per share. | 29 Apr 2024 | 2,686 | 527,427 | - | 6.4 | 17,137 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 7.70 per share. | 27 Mar 2024 | 765 | 530,113 | - | 7.7 | 5,891 | Common Stock |
| Relay Therapeutics Inc | A. Donald Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 9.64 per share. | 29 Jan 2024 | 3,178 | 530,878 | - | 9.6 | 30,636 | Common Stock |
| Relay Therapeutics Inc | A. Bergstrom Donald | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 300,000 | 534,056 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Bergstrom Donald A. | President, R&D | Sale of securities on an exchange or to another person at price $ 11.51 per share. | 27 Dec 2023 | 977 | 234,056 | - | 11.5 | 11,245 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 11.80 per share. | 28 Jul 2023 | 2,683 | 237,904 | - | 11.8 | 31,659 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 27 Jun 2023 | 647 | 240,587 | - | 12.1 | 7,842 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 11.16 per share. | 28 Apr 2023 | 2,850 | 241,234 | - | 11.2 | 31,806 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 15.36 per share. | 27 Mar 2023 | 763 | 244,084 | - | 15.4 | 11,720 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 21.56 per share. | 30 Jan 2023 | 1,429 | 244,847 | - | 21.6 | 30,809 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 160,390 | 160,390 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 160,390 | 246,276 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 160,390 | 160,390 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 14.49 per share. | 27 Dec 2022 | 980 | 85,886 | - | 14.5 | 14,200 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 28 Oct 2022 | 8,000 | 94,866 | - | 4.1 | 32,960 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 22.75 per share. | 28 Oct 2022 | 8,000 | 86,866 | - | 22.8 | 182,000 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 8,000 | 93,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 21.54 per share. | 28 Oct 2022 | 1,817 | 86,866 | - | 21.5 | 39,138 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 22.43 per share. | 03 Oct 2022 | 8,000 | 88,683 | - | 22.4 | 179,440 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 03 Oct 2022 | 8,000 | 96,683 | - | 4.1 | 32,960 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 8,000 | 101,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 22.73 per share. | 27 Sep 2022 | 976 | 88,683 | - | 22.7 | 22,184 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 25,000 | 109,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 08 Sep 2022 | 25,000 | 89,659 | - | 30 | 750,000 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 08 Sep 2022 | 25,000 | 114,659 | - | 4.1 | 103,000 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 02 Sep 2022 | 4,900 | 94,559 | - | 4.1 | 20,188 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 4,900 | 134,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 25.46 per share. | 02 Sep 2022 | 4,900 | 89,659 | - | 25.5 | 124,754 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 8,100 | 139,356 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 01 Sep 2022 | 8,100 | 97,759 | - | 4.1 | 33,372 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 23.07 per share. | 01 Sep 2022 | 8,100 | 89,659 | - | 23.1 | 186,867 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2022 | 15,000 | 147,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 24 Aug 2022 | 15,000 | 104,659 | - | 4.1 | 61,800 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 24 Aug 2022 | 15,000 | 89,659 | - | 25 | 375,000 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 05 Aug 2022 | 8,000 | 97,659 | - | 4.1 | 32,960 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 05 Aug 2022 | 8,000 | 89,659 | - | 20 | 160,000 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2022 | 8,000 | 162,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 21.27 per share. | 28 Jul 2022 | 1,835 | 89,659 | - | 21.3 | 39,030 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 06 Jul 2022 | 8,000 | 91,494 | - | 20 | 160,000 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2022 | 8,000 | 170,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 06 Jul 2022 | 8,000 | 99,494 | - | 4.1 | 32,960 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 24 Jun 2022 | 8,000 | 92,493 | - | 20 | 160,000 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 8,000 | 178,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 24 Jun 2022 | 8,000 | 100,493 | - | 4.1 | 32,960 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 20.31 per share. | 24 Jun 2022 | 999 | 91,494 | - | 20.3 | 20,290 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 13,000 | 186,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 24.62 per share. | 28 Apr 2022 | 13,000 | 92,493 | - | 24.6 | 320,060 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 28 Apr 2022 | 13,000 | 105,493 | - | 4.1 | 53,560 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 25.57 per share. | 28 Apr 2022 | 1,811 | 92,493 | - | 25.6 | 46,307 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 01 Apr 2022 | 18,000 | 112,304 | - | 4.1 | 74,160 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 18,000 | 199,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 30.32 per share. | 01 Apr 2022 | 18,000 | 94,304 | - | 30.3 | 545,760 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 29.87 per share. | 29 Mar 2022 | 622 | 94,304 | - | 29.9 | 18,579 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 24 Mar 2022 | 10,000 | 94,926 | - | 30 | 300,000 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2022 | 10,000 | 217,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 24 Mar 2022 | 10,000 | 104,926 | - | 4.1 | 41,200 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 23.88 per share. | 01 Mar 2022 | 8,000 | 94,926 | - | 23.9 | 191,040 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 8,000 | 237,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 01 Mar 2022 | 8,000 | 102,926 | - | 4.1 | 32,960 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 20.94 per share. | 22 Feb 2022 | 12,242 | 97,678 | - | 20.9 | 256,347 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 20.94 per share. | 22 Feb 2022 | 8,000 | 109,920 | - | 20.9 | 167,520 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 8,000 | 245,456 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 22 Feb 2022 | 8,000 | 117,920 | - | 4.1 | 32,960 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 20.97 per share. | 22 Feb 2022 | 2,752 | 94,926 | - | 21.0 | 57,709 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 129,900 | 129,900 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 64,950 | 109,920 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Donald A. Bergstrom | See Remarks | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 27 Dec 2021 | 649 | 44,970 | - | 33.1 | 21,482 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | See Remarks | Sale of securities on an exchange or to another person at price $ 34.15 per share. | 15 Oct 2021 | 30,000 | 45,619 | - | 34.2 | 1,024,500 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | See Remarks | Sale of securities on an exchange or to another person at price $ 36.87 per share. | 27 Sep 2021 | 646 | 75,619 | - | 36.9 | 23,818 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | See Remarks | Sale of securities on an exchange or to another person at price $ 35.81 per share. | 28 Jun 2021 | 976 | 76,265 | - | 35.8 | 34,951 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | See Remarks | Sale of securities on an exchange or to another person at price $ 33.75 per share. | 16 Jun 2021 | 42,242 | 77,241 | - | 33.8 | 1,425,668 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 16 Jun 2021 | 42,242 | 119,483 | - | 4.1 | 174,037 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2021 | 42,242 | 253,456 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Donald A. Bergstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Donald A. Bergstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | See Remarks | Sale of securities on an exchange or to another person at price $ 32.36 per share. | 16 Apr 2021 | 56,324 | 77,241 | - | 32.4 | 1,822,645 | Common Stock |
| Fusion Pharmaceuticals Inc | Donald A. Bergstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 69,998 | 69,998 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 34,999 | 133,565 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Donald A. Bergstrom | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 126,727 | 126,727 | - | - | Stock Option (Right to Buy) |